Marine Salze

Marine Salze

Auto-generated profile, based on publicly available information

Marine Salze

Affiliation Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2020 in RNA Biology
Verified
Journal Article
Closed access
MSMarine Salze
Marine Salze
CMCécile MULLER
Cécile MULLER
BBBenoit Bernay
Benoit Bernay
AHAxel Hartke
Axel Hartke
TCThomas Clamens
Thomas Clamens
ARAlain Rince
Alain Rince
The control of mRNA turnover is essential in bacteria to allow rapid adaptation, especially in opportunistic pathogen like Enterococcus faecalis. This mechanism involves RNase and DEAD-box helicases that are key elements in RNA processing and their associations form the degradosome with accessory proteins. In this study, we investigated the function of four RNases (J1, J2, Y and III) and three DEAD-box helicases (CshA, CshB, CshC) present in most Enterococci. The interactions of all these RNA metabolism actors were investigated in vitro, and the results are in accordance with a degradosome structure close to the one of Bacillus subtilis. At the physiological level, we showed that RNase J1 is essential, whereas RNases J2 and III have a role in cold, oxidative and bile salts stress response, and RNase Y in general fitness. Furthermore, RNases J2, Y and III mutants are affected in virulence in the Galleria mellonella infection model. Concerning DEAD-box helicases, all of them are involved in cold shock response. Since the ΔcshA mutant was the most stress impacted strain, we studied this DEAD-box helicase CshA in more detail. This showed that CshA autoregulates its own expression by binding to its mRNA 5ʹUnstranslated Region. Interestingly, CshC is also involved in the expression control of CshA by a hitherto unprecedented mechanism.

18 July 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMarine Salze
Marine Salze
SCSébastien Chrétien
Sébastien Chrétien
TBTegvir S. Boora
Tegvir S. Boora
MMMadalina Macovei
Madalina Macovei
EBEric Barbeau
Eric Barbeau
MAMartin Audet
Martin Audet
Prostaglandin F2ɑ (PGF2ɑ) is a bioactive lipid derived from arachidonic acid and is involved in many physiological and pathophysiological processes, such as parturition, vascular tone regulation, glaucoma and inflammation. It acts by binding to the Prostaglandin F2ɑ receptor (FP), a G Protein-Coupled Receptor (GPCR) that mediates signaling events by engaging intracellular heterotrimeric G protein effectors. The orthosteric binding site of lipid-binding receptors displays greater efficacy-dependent plasticity that hinders the design of ligands. Solving the structure of FP with ligands of different efficacies at an atomic level is important to fully understand its mechanism of activation and inhibition. Most purified FP-ligand complexes are unstable in vitro. The development of new X-ray crystallography and single particle cryo-electron microscopy (cryoEM) strategies to understand receptors’ signal transduction requires improved purification yield and in vitro stability of the receptor. Here, we present a protein engineering effort to optimize the FP protein sequence for use in structural biology. Strategies involve protein insertion sites in the third intracellular loop (ICL3), N-terminal and C-terminal deletions, and single-point mutations that favorably affect receptor purification yield and stability in vitro. The best FP construct displays a yield of 1.5 mg/L and a stability of 59oC, which constitute a threefold improvement in purification yield and 9oC increase in stability over the wild-type receptor. These modifications in the receptor are suitable for pursuing alternative strategies for improving FP purification yield and for studying FP binding efficacy to its ligands through structural biology approaches.

20 May 2022 in European Journal of Pharmacology
Verified
Journal Article
Closed access
CNClaire Normand
Claire Normand
BBBilly Breton
Billy Breton
MSMarine Salze
Marine Salze
EBEric Barbeau
Eric Barbeau
AMArturo Mancini
Arturo Mancini
MAMartin Audet
Martin Audet

3 April 2026
Verified
Thesis
Closed access
MSMarine Salze
Marine Salze
E. faecalis est une bactérie à gram positif, responsable d’infections nosocomiales. Dans cette étude, nous avons identifié par RNA-seq 65 ARN régulateurs potentiels induits en conditions de stress et/ou d’infection chez ce pathogène opportuniste. Parmi ceux-ci, trois ARN surexprimés in vivo, en présence de sels biliaires et à pH acide ont fait l’objet d’une étude approfondie.Le premier, SRC65, s’est avéré être un petit ARN (sARN) agissant probablement en trans. Il présenterait des fonctions redondantes avec son homologue SRC90. Différentes cibles potentielles ont été identifiées et des expériences de physiologie ont révélé un rôle de SRC65 dans le déclenchement de la phase exponentielle de croissance.Le 2ème ARN étudié est une région 5’ régulatrice non traduite (5’UTR), appelée 5’1515. Elle formerait un atténuateur et agirait de manière répressive sur le gène ef1515. EF1515 est un antiterminateur de la famille BglG/SacY capable de se fixer sur 5’1515 pour réguler son expression et celle du gène ef1516 localisé en aval et codant un système de transport des sucres de type PTS. L’antiterminateur EF1515 contrôle aussi l’expression du gène ef3023 codant une protéine impliquée dans la virulence d’E. faecalis.Le dernier ARN régulateur étudié est également une 5’UTR. Celle-ci participerait à la régulation d’une hélicase à motif DEAD (CshA) codée en aval de la 5’UTR. Sa caractérisation s’inscrit dans une étude plus large concernant les éléments du métabolisme des ARN, impliquant les ribonucléases et les autres hélicases à motif DEAD d’E. faecalis. CshA aurait un rôle prépondérant pour la bactérie, en étant impliquée dans la réponse au stress, le fitness et la virulence. L’identification de l’interactome de CshA a notamment permis d’identifier l’énolase comme partenaire privilégié.

20 February 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
MSMarine Salze
Marine Salze
SCSébastien Chrétien
Sébastien Chrétien
TBTegvir S. Boora
Tegvir S. Boora
MMMadalina Macovei
Madalina Macovei
EBEric Barbeau
Eric Barbeau
MAMartin Audet
Martin Audet
Prostaglandin F 2ɑ (PGF 2ɑ ) is a bioactive lipid derived from arachidonic acid and is involved in many physiological and pathophysiological processes such as parturition, vascular tone regulation, glaucoma and inflammation. It acts by binding to the Prostaglandin F 2ɑ receptor (FP), a G Protein-Coupled Receptor (GPCR) that mediates signaling events by engaging intracellular heterotrimeric G protein effectors. The orthosteric binding site of lipid-binding receptors displays greater efficacy-dependent plasticity that hinders the design of ligands. Solving the structure of FP with ligands of different efficacies at an atomic level is important to fully understand its mechanism of activation and inhibition. Most purified FP-ligand complexes are unstable in vitro . The development of new X-ray crystallography and single particle cryo-electron (cryoEM) strategies to understand receptors’ signal transduction requires improved purification yield and in vitro stability of the receptor. Here, we present a protein engineering effort to optimize the FP protein sequence for use in structural biology. Strategies involve protein insertion sites in the third intracellular loop (ICL3), N-terminal and C-terminal deletions, and single-point mutations that favorably affect receptor purification yield and stability in vitro . The best FP construct displays a yield of 1.5 mg/L and a stability of 59°C that constitute a threefold improvement in purification yield and 9°C increase in stability over the wild-type receptor. These modifications in the receptor are suitable for pursuing alternative strategies for improving FP purification yield and for studying FP binding efficacy to its ligands through structural biology approaches.